Search
Now showing items 1-10 of 30
An Observational Study Assessing Immediate Complete Versus Delayed Complete Revascularisation in Patients with Multi-Vessel Disease Undergoing Primary Percutaneous Coronary Intervention.
(Sage, 2020-08-21)
Background: More than half of the patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) have multi-vessel coronary artery disease. This is associated ...
COVID-19 and changes in activity and treatment of ST elevation MI from a UK cardiac centre.
(2021-04)
Background: The international healthcare response to COVID-19 has been driven by epidemiological data related to case numbers and case fatality rate. Second order effects have been less well studied. This study aimed to ...
Reply: Pitfalls of Unfractionated Heparin Use During ST-Segment Elevation Myocardial Infarction in Patients With COVID-19 Infection
(Elsevier, 2021-01-04)
Letter.
Refers to
Anne-Céline Martin, Anne Godier, Nicole Karam.
Pitfalls of Unfractionated Heparin Use During ST-Segment Elevation Myocardial Infarction in Patients With COVID-19 Infection.
Journal of the American ...
P2665 An observational study assessing the impact of a cardiac arrest centre on patient outcome
(2019-10-01)
Abstract P2665 from ESC Congress 2019 together with World Congress of Cardiology 31 August – 4 September 2019, Paris - France
The Use of Novel Oral Anti-Coagulant's (NOAC) compared to Vitamin K Antagonists (Warfarin) in patients with Left Ventricular thrombus after Acute Myocardial Infarction (AMI).
(2020-07-30)
AIM: Current guidelines recommend the use of Vitamin K Antagonist (VKA) for up to 3 - 6 months for treatment of LV thrombus post-acute myocardial infarction (AMI). However, based on evidence supporting non-inferiority of ...